| |
| |
| |
| |
| |
| | | | |
|
PR:A6NC86 | phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein (human) | | | | | |
| | | | | |
|
PR:A6NC86-1 | phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein isoform h1 (human) | | | | | |
| | | | | |
|
PR:A6NC86-2 | phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein isoform h2 (human) | | | | | |
| | | | | |
|
PR:A6NC86-3 | phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein isoform h3 (human) | | | | | |
| | | | | |
|
PR:A6NC86-4 | phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein isoform h4 (human) | | | | | |
| | | | | |
|
PR:000074364 | phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein methylated 1 (human) | | | | | |
| | |
|
PR:000031518 | phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein | | | | | |
| | | |
|
PR:A6NC86 | phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein (human) | | | | | |
| | | | |
|
PR:A6NC86-1 | phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein isoform h1 (human) | | | | | |
| | | | |
|
PR:A6NC86-2 | phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein isoform h2 (human) | | | | | |
| | | | |
|
PR:A6NC86-3 | phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein isoform h3 (human) | | | | | |
| | | | |
|
PR:A6NC86-4 | phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein isoform h4 (human) | | | | | |
| | | | |
|
PR:000074364 | phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein methylated 1 (human) | | | | | |